跳至主要内容
临床试验/EUCTR2007-004689-42-GB
EUCTR2007-004689-42-GB进行中(未招募)不适用

Insulin action and hypertension: effects of hyperaldosteronism and its treatment.

Belfast Health and Social Care Trust0 个研究点开始时间: 2008年6月17日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 20 patients aged under 70 years with mild essential hypertension will be recruited.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Presence of diabetes mellitus, significant obesity (BMI greater than 35kg/m2), a history of gout and pre-existing treatment with an agent which influences insulin action or treatment with potassium sparing diuretics will exclude participation, as will secondary hypertension, or diastolic blood pressure out with the range 80-105mmHg after 6 week placebo run-in. Pregnant women and breastfeeding mothers will be excluded, as will persons with significant hepatic or renal impairment.

研究者

相似试验